Md. company to study cancer medicine feasibility

ROCKVILLE — A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca. CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday. The two companies will work together to see whether they can transmit cancer drugs on extremely small gold particles. CytImmune works in developing nanomedicine, which [...]

E-Mail Newsroom


Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • HTML tags will be transformed to conform to HTML standards.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.